Udu-Ituma, S.; Adélaïde, J.; Le, T.K.; Omabe, K.; Finetti, P.; Paris, C.; Guille, A.; Bertucci, F.; Birnbaum, D.; Rocchi, P.;
et al. ZNF703 mRNA-Targeting Antisense Oligonucleotide Blocks Cell Proliferation and Induces Apoptosis in Breast Cancer Cell Lines. Pharmaceutics 2023, 15, 1930.
https://doi.org/10.3390/pharmaceutics15071930
AMA Style
Udu-Ituma S, Adélaïde J, Le TK, Omabe K, Finetti P, Paris C, Guille A, Bertucci F, Birnbaum D, Rocchi P,
et al. ZNF703 mRNA-Targeting Antisense Oligonucleotide Blocks Cell Proliferation and Induces Apoptosis in Breast Cancer Cell Lines. Pharmaceutics. 2023; 15(7):1930.
https://doi.org/10.3390/pharmaceutics15071930
Chicago/Turabian Style
Udu-Ituma, Sandra, José Adélaïde, Thi Khanh Le, Kenneth Omabe, Pascal Finetti, Clément Paris, Arnaud Guille, François Bertucci, Daniel Birnbaum, Palma Rocchi,
and et al. 2023. "ZNF703 mRNA-Targeting Antisense Oligonucleotide Blocks Cell Proliferation and Induces Apoptosis in Breast Cancer Cell Lines" Pharmaceutics 15, no. 7: 1930.
https://doi.org/10.3390/pharmaceutics15071930
APA Style
Udu-Ituma, S., Adélaïde, J., Le, T. K., Omabe, K., Finetti, P., Paris, C., Guille, A., Bertucci, F., Birnbaum, D., Rocchi, P., & Chaffanet, M.
(2023). ZNF703 mRNA-Targeting Antisense Oligonucleotide Blocks Cell Proliferation and Induces Apoptosis in Breast Cancer Cell Lines. Pharmaceutics, 15(7), 1930.
https://doi.org/10.3390/pharmaceutics15071930
